Relay Therapeutics, Inc.: cash_and_equivalents
| Value | {"amount": 145902000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2023-06-30) |
| Status | current |
| Entity | Relay Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:14:39.378863+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5b7d3319-a2e7-496d-847a-f5e80bd7e2c3
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-23-039874Retrieved: 2026-08-19T18:14:39.378863+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001812364/cash-and-equivalents/2023-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5b7d3319-a2e7-496d-847a-f5e80bd7e2c3
History
- no predecessors — first report